Loading

Month: July 2025

Semaglutide and the Risk of Blindness: What We Know So Far

Introduction: Semaglutide, sold under brand names such as Ozempic, Wegovy, and Rybelsus, is a glucagon-like peptide-1 receptor agonist (GLP-1 RA) widely used to manage type 2 diabetes and obesity. Praised for its effectiveness in reducing blood sugar and promoting weight loss, semaglutide has become one of the most prescribed drugs…
Read More
0
Shopping Cart (0 items)
Home
Shop
Appointment
Login